Costs

For participants of the electronic MEdical Records and GEnomics (eMERGE) Network phase IV study that are found to have high polygenic risk, the medical cost for some of the tests recommended in the Genome Informed Risk Assessment (GIRA) report for asthma, breast cancer, prostate cancer, and type I diabetes mellitus will be covered by study funds.

If you plan to order one of these tests for your patient who is an eMERGE IV study participant at Mayo Clinic in Rochester, Minnesota, contact the study team at RSTKulloLab@mayo.edu or 507-284-5467 to link the order to study funds. For Mayo Clinic clinicians, you can also staff message Jacob Petrzelka and Scott Nigbur in Epic.

If you plan to order one of these tests for your patient who is an eMERGE IV study participant at Mountain Park Hospital Center in Phoenix, Arizona, contact the study coordinators Cynthia Ramirez at cyramirez@mphc-az.org or Georgia Garza at ggarza@mphc-az.org to link the order to study funds.

Tests covered include:

Condition/ Disease Mayo Clinic Covered
Tests/Procedures
MPHC Covered
Tests/Procedures
Asthma One primary care visit for asthma risk assessment and education
  • One primary care visit for asthma risk assessment and education
  • Asthma specialist referral
  • Spirometry
Atrial Fibrillation None
  • Cardiology visit
  • ECG
  • Heart rhythm monitor
  • Echocardiogram
Breast Cancer
  • One-time mammogram for participants aged 25-39
  • One-time breast MRI for participants aged ≥ 25
  • One-time mammogram for participants aged 25-39 years
  • One-time breast MRI for participants aged ≥ 25 years
  • Breast examination by a clinician
  • Breast oncologist consultation
Chronic Kidney Disease None
  • Fasting blood glucose for adults
  • HbA1c
  • Serum creatinine
  • eGFR
  • Urinalysis
  • Blood pressure check
  • Nephrologist consultation
Coronary Heart Disease None
  • Lipid and Lp(a) levels
  • Carotid ultrasound for participants aged 18-40 years
  • Coronary calcium scan for participants aged ≥40 years
Hyper-
cholesterolemia
None
  • Lipid levels
  • Specialist referral
Obesity None
  • Primary care visit for obesity risk
  • Dietician/nutritionist referral
  • Healthy weight program referral
Prostate Cancer One-time PSA for participants aged 40-49
  • One-time PSA for participants aged 40-49 years
  • Rectal examination
Type I Diabetes Mellitus One-time autoantibody test
  • One-time autoantibody test
  • HbA1c
  • Fasting blood glucose
  • Urinalysis
  • Urinary ketone levels
  • Endocrinology consultation
Type II Diabetes Mellitus None
  • Fasting blood glucose in adults
  • HbA1c
  • Medical nutritionist consultation